男女性在钝性胸主动脉损伤行胸主动脉腔内修复术后死亡率相似
基于血管质量倡议(VQI)登记数据库2013至2022年数据,纳入1311例因钝性胸主动脉损伤(BTAI)行胸主动脉腔内修复术(TEVAR)的患者,其中女性占27%。校正混杂因素后,女性性别与围手术期死亡率、术后并发症及5年死亡率均无显著关联,但女性在索引住院期间再干预风险显著更高。
要点
- 女性BTAI患者行TEVAR后围手术期死亡率与男性无显著差异(7.1% vs 8.1%,OR 0.76,95%CI 0.43-1.3,P=0.34)。
- 女性索引住院期间再干预风险显著高于男性(OR 2.5,95%CI 1.1-5.5,P=0.024)。
- 男女5年死亡率无显著差异(HR 0.87,95%CI 0.57-1.35,P=0.50)。
核心结论
- 与胸主动脉瘤修复术后观察到的性别相关结局差异不同,BTAI患者行TEVAR后性别与围手术期结局或长期死亡率无显著关联。
- 作者认为这种性别相关结局的差异可能由病理、人口学和解剖因素的差异解释。
研究设计与样本
- 回顾性队列研究,利用血管质量倡议(VQI)登记数据库2013至2022年数据,纳入因BTAI行TEVAR且累及胸主动脉2至5区的患者,排除主动脉损伤分级(SVS分级系统)信息缺失者,共1311例,女性占27%。
- 采用多变量逻辑回归和Cox回归分别评估性别对围手术期结局和长期死亡率的影响。
主要发现
- 女性患者年龄显著大于男性(女性47岁[IQR 30-63] vs 男性38岁[IQR 28-55],P<.001),合并症率更高。
- 女性格拉斯哥昏迷评分中位数高于男性(15分[IQR 11-15] vs 14分[IQR 8-15],P=.028),但主动脉损伤分级和其他合并创伤无性别差异。
- 女性手术时间中位数长于男性(79分钟[IQR 52-119] vs 69分钟[IQR 48-106],P=.008),其余手术特征可比。
- 校正后,女性性别与围手术期死亡率无显著关联(7.1% vs 8.1%;OR 0.76;95%CI 0.43-1.3;P=.34)。
- 男女术后并发症发生率可比(26% vs 29%;OR 0.89;95%CI 0.52-1.5;P=.26),包括入路相关并发症(0.5% vs 0.8%;P=.83)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Prior literature has demonstrated worse outcomes for female patients after abdominal aortic aneurysm repair. Also, prior studies in the context of thoracic endovascular aneurysm repair (TEVAR) for thoracic aortic aneurysms have reported conflicting results regarding sex-related outcomes. Because the influence of sex on the outcomes after TEVAR for blunt thoracic aortic injuries (BTAIs) remains understudied, we evaluated the association between sex and outcomes after TEVAR for BTAI. METHODS: We identified patients who had undergone TEVAR for BTAIs in the Vascular Quality Initiative registry from 2013 to 2022 and included those who had undergone TEVAR within zones 2 to 5 of the thoracic aorta. Patients with missing information regarding the aortic injury grade (Society for Vascular Surgery aortic injury grading system) were excluded. We performed multivariable logistic regression and Cox regression to determine the influence of sex on the perioperative outcomes and long-term mortality, respectively. RESULTS: We identified 1311 patients, of whom 27% were female. The female patients were significantly older (female, 47 years [interquartile range (IQR), 30-63 years]; male, 38 years [IQR, 28-55 years]; P < .001) with higher rates of comorbidities. Although the female patients had had higher Glasgow coma scale scores (median, 15 [IQR, 11-15]; vs 14 [IQR, 8-15]; P = .028), no differences were found in the aortic injury grade or other coexisting traumatic injuries between the sexes. Apart from the longer procedure duration for the female patients (median, 79 minutes [IQR, 52-119 minutes]; vs 69 minutes [IQR, 48-106 minutes]; P = .008), the procedural characteristics were comparable. After adjustment, no significant association was found between female sex and perioperative mortality (7.1% vs 8.1%; odds ratio, 0.76; 95% confidence interval [CI], 0.43-1.3; P = .34). The male and female patients had had comparable rates of postoperative complications (26% vs 29%; odds ratio, 0.89; 95% CI: 0.52-1.5]; P = .26) including access-related complications (0.5% vs 0.8%; P=.83). However, females had a significantly higher risk for reintervention during the index admission (odds ratio, 2.5; 95% CI, 1.1-5.5; P = .024). No significant difference was found between the male and female patients with respect to 5-year mortality (hazard ratio, 0.87; 95% CI, 0.57-1.35; P = .50). CONCLUSIONS: Unlike the sex-based outcome disparities observed after thoracic aortic aneurysm repair, we found no significant association between sex and perioperative outcomes or long-term mortality after TEVAR for BTAIs. This contrast in the sex-related outcomes after other vascular pathologies might be explained by differences in the pathology, demographics, and anatomic factors in these patients.
引用
- Rastogi V, Romijn AC, Yadavalli SD, et al. Males and females have similar mortality after thoracic endovascular aortic repair for blunt thoracic aortic injury. J Vasc Surg. 2022. PMID: 36565777. doi:10.1016/j.jvs.2022.12.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。